TT-OAD2

TT-OAD2

• CAS Number: 2382719-60-8
• UNSPSC Description: TT-OAD2 is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist with an EC50 of 5 nM. TT-OAD2 has the potential for diabetes treatment[1][2].
• Target Antigen: GCGR
• Type: Reference compound
• Related Pathways: GPCR/G Protein
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/tt-oad2.html
• Purity: 99.77
• Solubility: DMSO : 110 mg/mL (ultrasonic)
• Smiles: O=C(O)[C@H](CC1=CC=C(C2=C(C)C(C)=NC=C2)C=C1)NC([C@H]3N([C@H](C4=CC=CC=C4)CC)CC5=C(C=C(OC[C@H](C6=CC=C(OCC7=CC=C(Cl)C(Cl)=C7)C=C6)O8)C8=C5)C3)=O.[H]Cl.[H]Cl
• Molecular Weight: 929.75
• References & Citations: [1]Zhao P, et al. Activation of the GLP-1 receptor by a non-peptidic agonist. Nature. 2020 Jan;577(7790):432-436.|[2]Transtech Pharma, et al. Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof. WO2010114824A1.
• Shipping Conditions: Room Temperature
• Storage Conditions: 4°C (Powder, sealed storage, away from moisture and light)
• Clinical Information: No Development Reported